Purdue Pharma announces agreement to end OxyContin patent lawsuit with Teva Pharmaceuticalstext editorEmerging Infectious Diseases
The plan calls for turning Purdue into a “public benefit trust” that would continue selling prescription opioids but use its profits for lawsuit settlements. The Sackler family would give up control of Purdue and contribute at least $3 billion toward the settlement. More than 20 states and the...
New York Attorney General Letitia James, like several others, sued Sackler family members and opposed the settlement before eventually agreeing to it this year. She said in a statement that if the deal doesn't hold up, she's ready to resume the civil lawsuit: "Purdue Pharma and the Sackler...
Eby said the settlement represents the start of action the province and Canada is taking to hold pharmaceutical companies, as well as their distributors and consultants, accountable. In addition to the Purdue Pharma settlement, B.C. is still waiting to certify its class-action lawsuit ...
(MORE: Purdue Pharma tries to 'cry poverty' in lawsuit over opioid epidemic, Connecticut attorney general says) Purdue also noted that the state of North Dakota recently dismissed a lawsuit filed by that state's attorney general with regard to the company's alleged role in the opioid crisis...
OxyContin maker Purdue Pharma is trying to chart the course for a new mass settlement of thousands of lawsuits over the toll of opioids after the U.S. Supreme Court last month rejected its previous deal, which was years in the making. ...
CHARLESTON, W.Va. (AP) — West Virginia Attorney General Patrick Morrisey said he will oppose OxyContin maker Purdue Pharma’s bankruptcy plan, arguing that his state, one of the hardest hit by the opioid epidemic, would get shorted in settlement money.
Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioids epidemic in the United States.
In internal correspondence beginning in 2014, Purdue Pharma executives discussed how the sale of opioids and the treatment of opioid addiction are “naturally linked” and that the company should expand across “the pain and addiction spectrum,” according to redacted sections of the lawsuit by the...
On Monday, the US Supreme Court grappled with one of thehighest-profile bankruptcy casesthe court has taken on in decades. The case hinges on the legality of OxyContin-maker Purdue Pharma’s multibillion-dollar bankruptcy plan — which would have the Sackler family, who once owned the pha...